Medtronic plc: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-09-28
⚠ AI Risk Brief Interpretation layer — deterministic data below

New litigation and Diabetes separation risks, alongside revisions to global, competitive, and technology risks, increase exposure despite removal of two tax and contracting risks.

Direction ↑ More concerning
ThemesRegulatory & LegalWorkforce & TalentStrategic execution and competition
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

2
New Risks
2
Removed
10
Modified
22
Unchanged
🟢 New in Current Filing Disclosure change8/10

We are subject to litigation, claims, investigations, and regulatory proceedings, which are inherently unpredictable and could materially adversely affect our business, results of operations, financial condition, and cash flows.

🟢 New in Current Filing The ongoing separation of our Diabetes Business could be delayed, may not be completed as currently contemplated, and could materially adversely affect our business, results of operations, financial condition, and cash flows. 🔒
🟡 Modified We are subject to a variety of risks associated with global operations that could adversely affect our profitability and operating results. 🔒
🟡 Modified Our success depends on our ability to differentiate our products and successfully execute and scale emerging technologies. 🔒

And 10 more changes in the full comparison.

13 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get Pro access Already a Pro subscriber? View full diff →